Know Cancer

forgot password

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Phase 1
Not Enrolling
Liver Cancer

Thank you

Trial Information

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Magnetic resonance imaging is taken with scanners at different magnetic field strength.
The current practice at UTMDACC is to perform these exams at 1.5 Tesla. Tesla is the unit
of strength of the magnetic field. This study will compare the images taken at the standard
1.5 Tesla (T) magnetic field with those at the newer 3.0T magnetic field.

You are already scheduled to receive a standard 1.5 T MR of the liver area as requested by
your doctor. As part of this study, you will then be asked to return on a separate date to
have a similar exam performed with the Signal 3.0T Excite MR scanner. You will return within
a two week period from the date of your first MRI examination. The examination will be
performed in a machine that looks similar to the 1.5T scanner. It will also take about the
same amount of time as the examination at 1.5T.

The images taken by both scanners will be evaluated and compared. After you have had the
second scan, your participation in this study will be over. If there are new findings
identified with the new scan your doctor will be notified.

This is an investigational study. The 3.0T scan will be performed free of charge. A total
of 20 patients will take part in this study All will be enrolled at UTMDACC.

This protocol is partially funded by a research grant from General Electric Medical Systems

Inclusion Criteria:

1. Patients with a liver lesion larger than 1cm detected by a prior imaging modality.

2. Patients have been scheduled and are eligible for an MRI of the abdomen or MRI of the
liver or MRI of the kidney examination.

Exclusion Criteria:

1) Patients who are unable to cooperate with breath hold.

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Janio Szklaruk, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

June 2004

Completion Date:

Related Keywords:

  • Liver Cancer
  • Liver Cancer
  • Magnetic Resonance Imaging
  • Signa Excite 3.0T MRI Scan
  • Liver Neoplasms



U.T.M.D. Anderson Cancer Center Houston, Texas  77030